November 07, 2025

Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and Real World Data on the Challenges and Resource Utilization of Managing Kidney Transplant Recipients at ASN Kidney Week Meeting

October 16, 2025

ChipSync and Cortus Join Forces to Offer Tailored RISC-V Automotive Solutions in India!

September 29, 2025

SmartSoC Solutions Partners with Cortus to Advance Chip Design and Manufacturing for SIM Cards, Smart Cards, Banking Cards, and E-Passports in India

August 19, 2025

Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science

July 25, 2025

Memo Therapeutics AG Announces Phase II Trial Results for Potravitug in Kidney Transplant Recipients with BKPyV Infection

July 22, 2025

Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation

February 24, 2025

Cortus MINERVA Out-of-Order 4GHz 64-bit RISC-V Processor Platform targets automotive applications